James Luccarelli
Overview
Explore the profile of James Luccarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Srinivasan A, Luccarelli J, Tamargo R, Adegoke T, Smith J
J Child Adolesc Psychopharmacol
. 2025 Mar;
PMID: 40040484
Catatonia is a severe psychomotor and mood-related disorder, which can significantly impact the quality of life for autistic individuals. Often, electroconvulsive therapy (ECT) is required for treatment of catatonia in...
2.
Wade B, Pindale R, Luccarelli J, Li S, Meisner R, Seiner S, et al.
NPJ Digit Med
. 2025 Feb;
8(1):127.
PMID: 40016503
Electroconvulsive therapy (ECT) and ketamine are effective treatments for depression; however, evidence-based guidelines are needed to inform individual treatment selection. We adapted the Personalized Advantage Index (PAI) using machine learning...
3.
Gunther M, Luccarelli J, Beach S
Gen Hosp Psychiatry
. 2025 Feb;
93:86-88.
PMID: 39891951
No abstract available.
4.
Smith J, Lim S, Bindra S, Marler S, Rajah B, Williams Z, et al.
Autism Res
. 2025 Jan;
18(2):449-462.
PMID: 39866085
Catatonia is a highly morbid psychomotor and affective disorder, which can affect autistic individuals with and without intellectual disability. Catatonic symptoms are treatable with pharmacotherapy and electroconvulsive therapy, but the...
5.
Wachtel L, Luccarelli J, Falligant J, Smith J
Curr Opin Psychiatry
. 2025 Jan;
38(2):79-86.
PMID: 39804212
Purpose Of Review: Over the last quarter century, the clinical evidence surrounding the use of electroconvulsive therapy (ECT) in individuals with autism spectrum disorder (ASD) has expanded. This review provides...
6.
Luccarelli J, Strong T, Rubin E, McCoy Jr T
Am J Med Genet A
. 2025 Jan;
e63980.
PMID: 39797665
Prader-Willi syndrome (PWS) is a genetic disorder associated with baseline respiratory impairment caused by multiple contributing etiologies. While this may be expected to increase the risk of severe COVID-19 infections...
7.
Luccarelli J, Smith J, Kalinich M, Amad A, Rogers J
J Neuropsychiatry Clin Neurosci
. 2025 Jan;
:appineuropsych20240072.
PMID: 39789943
Objective: Catatonia is a neuropsychiatric disorder that is associated with a range of medical and psychiatric illnesses. Although many single-center studies have been conducted, uncertainty over the population-based incidence and...
8.
Dotson S, Luccarelli J
J Am Acad Child Adolesc Psychiatry
. 2024 Dec;
PMID: 39709007
We read with interest the Commentary by Jeffrey et al. encouraging clinical research using psychedelics for adolescents. Throughout their commentary, the authors operate under the general presupposition that psychedelics have...
9.
Luccarelli J, Kalinich M, Wilson J, Liu J, Fuchs D, Francis A, et al.
medRxiv
. 2024 Dec;
PMID: 39649599
Introduction: Catatonia is a neuropsychiatric disorder marked by significant disturbances in motor, cognitive, and affective functioning and that is frequently under-diagnosed. To enhance clinical detection of catatonia, this study aimed...
10.
Luccarelli J, Smith J, Heckers S, Fricchione G, Wilson J
Schizophr Res
. 2024 Nov;
274:486-488.
PMID: 39515258
No abstract available.